Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
darbepoetin alfa SF · 1 trial · 2 indications
| Arm | Type | Description |
|---|---|---|
| darbepoetin alfa SF | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| darbepoetin alfa SF | DRUG | Frequency of dosing depends on frequency at randomization: rHuEPO QW = darbepoetin alfa SF Q2W (dosing conversion table in protocol) rHuEPO biw or tiw = darbepoetin alfa SF QW (dosing conversion table in protocol) darbepoetin alfa RB = darbepoetin alfa SF at same dose and frequency PFS 10, 15, 20, 30, 40, 50, 60, 80, 100, 150, 200 or 300 mcg; Hb maintained between 11.0 - 13.0 g/dL |
Inclusion Criteria: * Currently diagnosed with Chronic Kidney Disease, either receiving or not receiving dialysis * Anemic * Currently on erythropoietic therapy * Controlled hypertension * Clinically stable
Top 20 of 25 competitors